Arca
Skip to content

Trio Monitor

Monitor, Physiological, Patient (Without Arrhythmia Detection Or Alarms). 510(k) K041907, from Datascope Corp. (Mahwh, NJ). Product code MWI, class 2.

As of Nov 17, 2026, K041907 is an FDA 510(k) held by Datascope Corp., substantially equivalent on Jul 23, 2004 after 8 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Jul 23, 2004
  • Review time: 8 days
  • Recalls: 0

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

INDICATION FOR USE STATEMENT The Trio TM monitor is intended for use in healthcare settings under the direct supervision of a licensed healthcare practitioner. The intended use of the monitor is to monitor physiologic parameter data on adult and pediatric patients.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other MWI Clearances

The newest 510(k)s for the same product code; their median review was 270 days; see every MWI device

Record

Type
Abbreviated, third-party review
Received
Jul 15, 2004
Review panel
Cardiovascular
Regulation
21 CFR 870.2300

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.